We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy

News   Jul 03, 2017 | Original story from St. Jude Children’s Research Hospital

 
Epigenetic Reprogramming May Significantly Enhance Immunotherapy Efficacy

(from left) Corresponding author Benjamin Youngblood, Ph.D., is with first author Hazem Ghoneim, Ph.D. Credit: St. Jude Children’s Research Hospital

 
 
 

RELATED ARTICLES

Daily Exposure to Blue Light May Accelerate Aging

News

New research using fruit flies suggests that blue light could damage cells and may accelerate aging.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

Embryo’s Early Development Revealed in a Dish

News

During embryonic development, the entire nervous system, the skin and the sensory organs emerge from a single sheet of cells known as the ectoderm. While there have been extensive studies of how this sheet forms all these derivatives, it hasn't been possible to study the process in humans - until now.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Drug Discovery Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE